NCT05274243View on ClinicalTrials.gov

2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Rheumatoid Arthritis
Interventions
DRUG

2-HOBA

2-HOBA acetate (2-Hydroxybenzlamine acetate) 750mg (provided as three 250mg capsules) three times per day for 4 weeks

OTHER

Placebo

Placebo (provided as three capsules) three times a day for 4 weeks

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER